-
IntelliPharmaCeutics Surges After Company Reports Successful Bioequivalence Results
Thursday, January 14, 2016 - 12:57pm | 248Shares of IntelliPharmaCeutics Intl Inc (NASDAQ: IPCI), a micro-cap pharmaceutical company that manufacturers novel and generic controlled-release oral solid dosage drugs, surged higher by more than 15 percent on Thursday. IntelliPharmaCeutics announced that a bioequivalence trial of its...